TET2 clonal hematopoiesis
搜索文档
Caris Data Validates TET2 Clonal Hematopoiesis as a Biomarker for Enhanced Immunotherapy Response
Prnewswire· 2025-10-29 20:30
Caris was founded with a vision to realize the potential of precision medicine in order to improve the human condition. Headquartered in Irving, Texas, Caris has offices in Phoenix, New York, Cambridge (MA), Tokyo, Japan and Basel, Switzerland. Caris or its distributor partners provide services in the U.S. and other international markets. Forward Looking StatementsThis press release contains forward-looking statements within the meaning of the federal securities laws. All statements other than statements ...